P&G Toothpaste, Sleep Aid Sales Drive Health Care Unit Gains
This article was originally published in The Tan Sheet
Executive Summary
P&G’s U.S. business is the star of the last quarter thanks in part to increases in consumer health categories and top brands in particular. An analyst says the firm appears to be turning a corner after several weak quarters.
You may also be interested in...
P&G Will Cut More Staff To Help Fund Innovation
During its annual meeting with analysts, Procter & Gamble announces it will continue cutting staff to help finance new innovations, and plans to introduce three times more “breakthrough” innovations in the next five years than were achieved in the previous five years.
P&G Launches ZzzQuil To Enter OTC Sleep Aid Category
While other national brand names compete in the OTC sleep aid tablet category, P&G’s NyQuil line extension is by far the biggest name among current players in the liquid product category, which has annual growth of nearly 80%.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.